Get the Stockscreener App
2.49
1.22%
0.03
After Hours:
2.47
-0.02
-0.80%
Microbot Medical Inc stock is traded at $2.49, with a volume of 2.86M.
It is up +1.22% in the last 24 hours and up +50.00% over the past month.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
See More
Previous Close:
$2.46
Open:
$2.49
24h Volume:
2.86M
Relative Volume:
0.91
Market Cap:
$79.22M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-2.075
EPS:
-1.2
Net Cash Flow:
$-9.21M
1W Performance:
+39.11%
1M Performance:
+50.00%
6M Performance:
+158.03%
1Y Performance:
+176.67%
1-Day Range:
$2.37
$2.6398
1-Week Range:
$1.83
$2.6398
52-Week Range:
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.49 | 79.22M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Yahoo Finance
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Stock Soars: Is the Rally Sustainable? - timothysykes.com
Microbot Medical Presents Successful Trial Results for LIBERTY System - TipRanks
Microbot Medical stock rises on trial win (MBOT:NASDAQ) - Seeking Alpha
Microbot Medical® Shares Results From Its Pivotal Clinical Trial - MarketScreener
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic ... - Bluefield Daily Telegraph
Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire
Groundbreaking Clinical Trial: New Robotic System Cuts Surgeon Radiation by 92% - Stock Titan
Microbot Medical (NASDAQ:MBOT) Shares Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Microbot Medical to Present ACCESS-PVI Trial Data - TipRanks
REMINDER: Microbot Medical Announces Data from the - GlobeNewswire
Groundbreaking Clinical Trial Results: Revolutionary Endovascular Robot Faces Critical FDA Decision - Stock Titan
Microbot Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Microbot Medical Inc. (MBOT) reports earnings - qz.com
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
MICROBOT MEDICAL Earnings Preview: Recent $MBOT Insider Trading, Hedge Fund Activity, and More - Nasdaq
Microbot Medical Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - Defense World
Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Microbot Medical Stock Price, Quotes and Forecasts | NASDAQ:MBOT - Benzinga
Microbot Medical names Paul Mullen as VP, sales - Medical Buyer
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints New VP Ahead of Product Launch - TipRanks
Microbot Medical appoints Paul Mullen as VP, sales - TipRanks
Microbot Medical Appoints Seasoned Endovascular Sales Executive To Lead Its U.S. Sales Activities For LIBERTY® Endovascular Robotic System - MENAFN.COM
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):